Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An inherited myopathy caused by mutations in the ACTA1 gene, encoding actin, alpha skeletal muscle. The phenotype is highly variable, and as such attempts at classification by clinical features is not optimal. Generally, affected individuals have generalized muscle weakness, typically involving proximal muscles, the face, bulbar and respiratory muscles.
Features include sometimes findings: Hypertonia, Muscle stiffness (rigidity), Overactive reflexes (hyperreflexia), and Enlarged and weakened heart (dilated cardiomyopathy). 38 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 12 | Limb muscle weakness, Type 1 muscle fiber predominance, Proximal muscle weakness |
Genetic testing for ACTA1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for congenital myopathy 2a, typical, autosomal dominant has been reported in the published literature.
No clinical trials have been registered for congenital myopathy 2a, typical, autosomal dominant.
4 publications have been identified in PubMed for congenital myopathy 2a, typical, autosomal dominant. Research spans Basic Science / Preclinical (50%), Diagnostic / Biomarker (25%), and Epidemiology / Natural History (25%).
Hildebrandt C (2025). [PMID: 40661861](https://pubmed.ncbi.nlm.nih.gov/40661861/). *Neurology. Genetics*. [Epidemiology / Natural History]
de Feraudy Y (2024). [PMID: 38982518](https://pubmed.ncbi.nlm.nih.gov/38982518/). *Genome medicine*. [Diagnostic / Biomarker]
Garg A (2024). [PMID: 39503885](https://pubmed.ncbi.nlm.nih.gov/39503885/). *Proceedings of the National Academy of Sciences of the United States of America*. [Basic Science / Preclinical]
Bui MT (2024). [PMID: 39707553](https://pubmed.ncbi.nlm.nih.gov/39707553/). *Acta neuropathologica communications*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Brain and nerves
7 |
Muscle stiffness (rigidity), Waddling gait, Spinal rigidity |
Head and neck | 2 | Facial palsy, High palate |
Digestive system | 2 | Feeding difficulties in infancy, Difficulty swallowing (dysphagia) |
Bones and joints | 2 | Excessive inward curvature of the lower spine (hyperlordosis), Sideways curvature of the spine (scoliosis) |
Lungs and breathing | 2 | Difficulty breathing (respiratory insufficiency), Difficulty breathing due to muscle weakness (respiratory insufficiency due to muscle weakness) |
Pregnancy and birth | 2 | Decreased fetal movement, Neonatal hypotonia |
Arms and legs | 1 | Limb muscle weakness |
Heart and blood vessels | 1 | Enlarged and weakened heart (dilated cardiomyopathy) |
Lab test results | 1 | Mildly elevated creatine kinase |